Effect of insulin on uric acid excretion in humans. 1995

A Quiñones Galvan, and A Natali, and S Baldi, and S Frascerra, and G Sanna, and D Ciociaro, and E Ferrannini
Metabolism Unit, University of Pisa, Italy.

Although hyperuricemia is a frequent finding in insulin-resistant states, insulin's effect on renal uric acid (UA) handling is not known. In 20 healthy volunteers, diastolic blood pressure, body weight, and fasting plasma insulin were positively (and age was negatively) related to fasting plasma UA concentrations, together accounting for 53% of their variability. During an insulin clamp, urine flow was lower than during fasting conditions (1.01 +/- 0.12 vs. 1.56 +/- 0.32 ml/min, P = 0.04), whereas creatinine clearance was unchanged (129 +/- 7 and 131 +/- 9 ml/min, P = not significant). Hyperinsulinemia did not alter serum UA concentrations (303 +/- 13 vs. 304 +/- 12 microM) but caused a significant decrease in urinary UA excretion [whether expressed as absolute excretion rate (1.66 +/- 0.21 vs. 2.12 +/- 0.23 mumol/min, P = 0.03), clearance rate (5.6 +/- 0.8 vs. 7.3 +/- 0.8 ml/min, P = 0.03), or fractional excretion (4.48 +/- 0.80 ml/min vs. 6.06 +/- 0.64%, P < 0.03)]. Hyperinsulinemia was also associated with a 30% (P < 0.001) fall in urine Na excretion. Fractional UA excretion was related to Na fractional excretion under basal conditions (r = 0.59, P < 0.01) and during the insulin period (r = 0.53, P < 0.02). Furthermore, the insulin-induced changes in fractional UA and Na excretion correlated with one another (r = 0.66, P < 0.001). Physiological hyperinsulinemia acutely reduces urinary UA and Na excretion in a coupled fashion.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009318 Natriuresis Sodium excretion by URINATION. Natriureses
D011188 Potassium An element in the alkali group of metals with an atomic symbol K, atomic number 19, and atomic weight 39.10. It is the chief cation in the intracellular fluid of muscle and other cells. Potassium ion is a strong electrolyte that plays a significant role in the regulation of fluid volume and maintenance of the WATER-ELECTROLYTE BALANCE.
D003404 Creatinine Creatinine Sulfate Salt,Krebiozen,Salt, Creatinine Sulfate,Sulfate Salt, Creatinine
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012964 Sodium A member of the alkali group of metals. It has the atomic symbol Na, atomic number 11, and atomic weight 23. Sodium Ion Level,Sodium-23,Ion Level, Sodium,Level, Sodium Ion,Sodium 23

Related Publications

A Quiñones Galvan, and A Natali, and S Baldi, and S Frascerra, and G Sanna, and D Ciociaro, and E Ferrannini
August 1959, The New England journal of medicine,
A Quiñones Galvan, and A Natali, and S Baldi, and S Frascerra, and G Sanna, and D Ciociaro, and E Ferrannini
January 1976, Physiologia Bohemoslovaca,
A Quiñones Galvan, and A Natali, and S Baldi, and S Frascerra, and G Sanna, and D Ciociaro, and E Ferrannini
January 1929, The Biochemical journal,
A Quiñones Galvan, and A Natali, and S Baldi, and S Frascerra, and G Sanna, and D Ciociaro, and E Ferrannini
January 1980, Advances in experimental medicine and biology,
A Quiñones Galvan, and A Natali, and S Baldi, and S Frascerra, and G Sanna, and D Ciociaro, and E Ferrannini
October 2015, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases,
A Quiñones Galvan, and A Natali, and S Baldi, and S Frascerra, and G Sanna, and D Ciociaro, and E Ferrannini
October 1970, The American journal of physiology,
A Quiñones Galvan, and A Natali, and S Baldi, and S Frascerra, and G Sanna, and D Ciociaro, and E Ferrannini
January 1988, Drugs,
A Quiñones Galvan, and A Natali, and S Baldi, and S Frascerra, and G Sanna, and D Ciociaro, and E Ferrannini
November 1987, Japanese journal of pharmacology,
A Quiñones Galvan, and A Natali, and S Baldi, and S Frascerra, and G Sanna, and D Ciociaro, and E Ferrannini
December 1962, The American journal of medicine,
A Quiñones Galvan, and A Natali, and S Baldi, and S Frascerra, and G Sanna, and D Ciociaro, and E Ferrannini
June 1978, European journal of clinical pharmacology,
Copied contents to your clipboard!